Shares of Nvidia Corp. fell almost 6% yesterday after the Competition and Markets Authority (CMA) announced that it would be investigating Nvidia’s $40 billion deal to...
It may be two months before Moderna and the NIH can conclude whether they can halve their vaccine dose and provide the same level of protection
The full 2-dose regimen efficacy of AstraZeneca Covid-19 vaccine was 62%, compared with 95% efficacy for Pfizer/BioNTech
What's Behind Today's Sudden Selloff: The Answer Lies In Georgia
Shares of Tiziana Life Sciences jumped 16% in Monday's pre-market trading after the biotech company announced the completion of the Brazil clinical trial of its nasally...
Pfizer and its German partner BioNTech are planning to offer free vaccination to those volunteers who received a placebo that remain in the Phase 4 study.
Investing in a state of fear is to buy likely winners and hedge away the fear.
RedHill Biopharma Ltd. said that preliminary data results from the US Phase 2 study of its opaganib administered in patients hospitalized with COVID-19 pneumonia demonstrated positive...
Shares of AMC Entertainment dropped 5.7% after the theatre operator filed a shelf offering with the SEC to sell 50 million shares to raise up to...
Regeneron Pharmaceuticals revealed encouraging initial data from its ongoing Phase 1/2/3 clinical trial of its antibody cocktail (casirivimab and imdevimab) in hospitalized COVID-19 patients on low-flow...
Moderna reaches an agreement to supply the government of South Korea with 20 million or more doses of its COVID-19 vaccine.
Arcturus Therapeutics announced that the Singapore Health Sciences Authority approved the start of the Phase 2 clinical study of its COVID-19 vaccine candidate ARCT-021.
AstraZeneca’s COVID-19 vaccine will be effective against the new variant of the virus
Where Analysts Are Most Optimistic And Pessimistic On Company Ratings For 2021
Inovio Pharmaceuticals reported that Phase 1 clinical trial data showed that the COVID-19 vaccine candidate was immunogenic in 100% of the participants and induced neutralizing antibody...
Moderna announced that Canada has authorized the use of its COVID-19 vaccine for the immunization of people aged 18 years and older. Shares closed 3.5% higher...
Merck & Co. has signed a $356 million deal with the U.S. government to develop, manufacture, and distribute an experimental COVID-19 therapy.
Walmart Shares Slide After DoJ Sues US' Biggest Retailer For "Fueling The Opioid Crisis"
While this initially sent the markets into a panic...
Moderna’s COVID-19 vaccine is second to receive US FDA EUA approval
Pfizer and German partner BioNTech will start distribution of the first doses of its BNT162b2 in Switzerland after the country’s regulatory agency granted authorization.
UK Warns Of Highly Infectious New Coronavirus Strain Discovered In Southern England Tyler Durden Mon, 12/14/2020 - 12:12 Remember all those Twitter armchair analysts who whined...
Mesoblast, on Friday, reported a failure in achieving the 30-day mortality reduction endpoint during its COVID-19 ARDS (acute respiratory distress syndrome) trial.
Abbott Laboratories has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for its virtually guided at-home BinaxNow COVID-19 Ag Card...
A new activist investor firm called Engine No. 1 is leading an effort from frustrated investors to overthrow ExxonMobil's board of directors, according to CNN Business....
We still need to know exactly what part of the immune response offers protection – and how strong it needs to be to remain protective.
A U.S. Centers for Disease Control and Prevention advisory panel on Dec. 12 recommended the nation’s first COVID-19 vaccine, helping clear the way for public health...
The U.S. government will get an additional 100 million doses of Moderna Inc.'s Covid-19 vaccine candidate, expected to be delivered in the second quarter of 2021...
MetLife, Inc. has announced that it will sell its Metropolitan Property and Casualty Insurance unit to a subsidiary of the Zurich Insurance Group, in an all-cash...
Investing is all about profits, and part of generating profits is knowing when to start the game. The old adage says to buy low and sell...